Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)
Clinical trial NCT04888663 · UNKNOWN
Trial details
- NCT number
- NCT04888663
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-13
- Primary completion
- 2021-09-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.